Outset Medical

Outset Medical

Dialysis treatment and training solutions

About

Outset Medical improves dialysis treatment by offering the Tablo system, which integrates with electronic medical record (EMR) platforms to streamline workflows and manage patient data effectively. They provide educational programs and hands-on training for dialysis professionals, including a Vascular Access Program and a Bridge Program to support facilities transitioning to in-house dialysis services. Outset Medical stands out by delivering comprehensive care solutions for hospitals, outpatient clinics, and home care settings. Their goal is to enhance the quality of care for dialysis patients through effective training and advanced technology.

Company Stage

IPO

Employees

501-1,000

Industries

Healthcare

Total Funding

$378.4M

Headquarters

N/A

Founded

2010


Simplify Jobs

Simplify's Take

What believers are saying

  • The $125 million Series E financing round led by D1 Capital Partners indicates strong investor confidence and provides substantial capital for growth and innovation.
  • Partnerships with organizations like U.S. Renal Care and the American Nephrology Nurses Association enhance Outset Medical's credibility and expand its market reach.
  • The long-term distribution agreement with Trace Medical for the Tablo Hemodialysis System opens new revenue streams and broadens the company's customer base.

What critics are saying

  • Ongoing investigations by law firms like Portnoy and Pomerantz into possible securities violations could damage the company's reputation and financial stability.
  • Insider selling activity, as noted by Perpetual Ltd, may indicate potential internal issues or lack of confidence among company executives.

What makes Outset Medical unique

  • Outset Medical's Tablo system integrates seamlessly with EMR platforms, offering real-time updates and alerts, which is a significant advantage over traditional dialysis systems.
  • The company's comprehensive training programs, including the Vascular Access and Bridge Programs, provide unique support to healthcare facilities transitioning to in-house dialysis services.
  • FDA clearance of the TabloCart with prefiltration underscores Outset Medical's commitment to innovation and flexibility in dialysis treatment.

Help us improve and share your feedback! Did you find this helpful?


Growth & Insights
Headcount

6 month growth

-10%

1 year growth

-15%

2 year growth

-5%

Benefits

Medical, dental, & vision

Life Insurance/AD&D

FSA & HSA

401k

Parental leave

Pet insurance

Tuition reimbursement

PTO

Company events

Recently Posted Jobs

Sign up to get curated job recommendations

Outset Medical is Hiring for 0 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update Outset Medical's jobs every 8 hours, so check again soon! Browse all jobs →